Dermatology

As cannabis use continues to surge across the United States, a growing body of research is shedding light on its underrecognized dermatological consequences.

In a significant advancement for the management of prurigo nodularis, a chronic and debilitating skin condition, a new systematic review highlights the promise of emerging biologic and targeted therapies that directly address the disease’s immune and neurogenic drivers.

Eye drop pain during routine exams may offer more than momentary discomfort, it could serve as an early marker of dry eye syndrome, according to a new study that reveals the link between pain sensitivity and ocular surface health.

Non-genetic factors such as age, allergies, smoking, and prior history of angioedema may significantly increase the risk of angioedema in patients taking ACE inhibitors or angiotensin receptor blockers, according to new pharmaco-epidemiological research.

New analysis shows promising repigmentation with JAK inhibitors in vitiligo, especially in combination with UVB. Safety and long-term outcomes remain key research needs.

Dermatological conditions in polar environments are gaining new attention as research missions to the Arctic and Antarctic expand.

Persistent acne scarring remains a major concern for patients and clinicians alike, with many individuals turning to invasive procedures in search of effective relief.

Biologic therapies targeting interleukin (IL)-17 and IL-23 have transformed the treatment landscape for plaque psoriasis, but questions remain about how these therapies perform in elderly patients compared to younger adults.